These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17413905)

  • 61. The effect of aprotinin on blood loss in bilateral total knee arthroplasty.
    Kinzel V; Shakespeare D; Derbyshire D
    Knee; 2005 Apr; 12(2):107-11. PubMed ID: 15749445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
    Ray MJ; Marsh NA
    Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Case control study of gastrointestinal complications after cardiopulmonary bypass heart surgery.
    Zhang G; Wu N; Liu H; Lv H; Yao Z; Li J
    Perfusion; 2009 May; 24(3):173-8. PubMed ID: 19755467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.
    Uitte de Willige S; De Visser MC; Vos HL; Houwing-Duistermaat JJ; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2008 Mar; 6(3):478-85. PubMed ID: 18182036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass.
    Pretorius M; Donahue BS; Yu C; Greelish JP; Roden DM; Brown NJ
    Circulation; 2007 Sep; 116(11 Suppl):I1-7. PubMed ID: 17846288
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Randomized study of aprotinin effect on transfusions and blood loss in primary THA.
    Colwell CW; Chelly JE; Murkin JM; Stevens D; O'Keefe TJ; Hall R; Parvizi J
    Clin Orthop Relat Res; 2007 Dec; 465():189-95. PubMed ID: 17767075
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ; Griesdale DE; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Factor V Leiden in patients with venous thrombosis in Slovak population.
    Simkova M; Batorova A; Dostalova K; Pozgayova S; Simko F; Kovacs L
    Gen Physiol Biophys; 2004 Dec; 23(4):435-42. PubMed ID: 15815078
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Excessive bleeding and transfusion in a prior cardiac surgery is associated with excessive bleeding and transfusion in the next surgery.
    Nuttall GA; Henderson N; Quinn M; Blair C; Summers L; Williams BA; Oliver WC; Santrach PJ
    Anesth Analg; 2006 Apr; 102(4):1012-7. PubMed ID: 16551890
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of aprotinin in pediatric lung transplantation.
    Jaquiss RD; Huddleston CB; Spray TL
    J Heart Lung Transplant; 1995; 14(2):302-7. PubMed ID: 7540042
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thrombophilia in cardiac surgery-patients with symptomatic factor V Leiden.
    Massoudy P; Thielmann M; Müller-Beissenhirtz H; Görlinger K; Dietrich W; Herget-Rosenthal S; Jakob H
    J Card Surg; 2009; 24(4):379-82. PubMed ID: 19040405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aprotinin in cardiac surgery: a different point of view.
    Immer FF; Jent P; Englberger L; Stalder M; Gygax E; Carrel TP; Tevaearai HT
    Heart Surg Forum; 2008; 11(1):E9-12. PubMed ID: 18270146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation.
    Goldstein DJ; Oz MC; Smith CR; Friedlander JP; De Rosa CM; Mongero LB; Delphin E
    Ann Thorac Surg; 1996 Feb; 61(2):692-5. PubMed ID: 8572789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Perioperative outcomes of cardiac surgery in kidney and kidney-pancreas transplant recipients.
    John R; Lietz K; Huddleston S; Matas A; Liao K; Shumway S; Joyce L; Bolman RM
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1212-9. PubMed ID: 17467431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiopulmonary bypass and left ventricular systolic dysfunction impacts operative mortality differently in elderly and young patients.
    Ngaage DL; Cowen ME; Cale AR
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):235-40. PubMed ID: 19084419
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Factor V Leiden protects against blood loss and transfusion after cardiac surgery.
    Donahue BS; Gailani D; Higgins MS; Drinkwater DC; George AL
    Circulation; 2003 Feb; 107(7):1003-8. PubMed ID: 12600914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The efficacy of aprotinin in arterial switch operations in infants.
    Murugesan C; Banakal SK; Garg R; Keshavamurthy S; Muralidhar K
    Anesth Analg; 2008 Sep; 107(3):783-7. PubMed ID: 18713883
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.
    Sirgo G; Morales P; Rello J
    Eur J Anaesthesiol; 2009 May; 26(5):404-11. PubMed ID: 19521296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.